Short-term mechanical unloading and reverse remodeling of failing hearts in children

Journal of Heart and Lung Transplantation

Volumn 29, Issue 1, 2010, Pages 98-104

  Mohapatra, Bhagyalaxmi ^a   Vick III, G Wesley ^a   Fraser Jr , Charles D ^a   Clunie, Sarah K ^a   Towbin, Jeffrey A ^d   Sinagra, Gianfranco ^b   Vatta, Matteo ^a,c  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TRIESTE   (Italy)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

children; cytoskeletal proteins; dystrophin; hear failure; LVAD; reverse remodeling; short term

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DYSTROPHIN; INOTROPIC AGENT; METOPROLOL;

APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CASE REPORT; CELL DIFFERENTIATION; CELL GROWTH; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE REMOVAL; FEMALE; GENE EXPRESSION; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMPLANTATION; INFANT; MALE; MOLECULAR MODEL; PILOT STUDY; PRIORITY JOURNAL; PROTEIN STRUCTURE; PULSATILE FLOW; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SHORT COURSE THERAPY; UPREGULATION;

BIOPSY; CASPASE 3; CHILD, PRESCHOOL; CYTOSKELETAL PROTEINS; DYSTROPHIN; FEMALE; GENE EXPRESSION PROFILING; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; PILOT PROJECTS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 72549094015     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.06.030     Document Type: Article

References (20)

1. Manolio T.A., Baughman K.L., Rodeheffer R., et al. Prevalence and etiology of idiopathic dilated cardiomyopathy. Am J Cardiol 69 (1992) 1458-1466
2. Mancini D., and Burkhoff D. Mechanical device-based methods of managing and treating heart failure. Circulation 112 (2005) 438-448
3. Vatta M., Stetson S.J., Perez-Verdia A., et al. Molecular remodeling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance device therapy. Lancet 359 (2002) 936-941
4. Vatta M., Stetson S.J., Jimenez S., et al. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow type ventricular assist devices. J Am Coll Cardiol 43 (2004) 811-817
5. Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93 (1996) 704-711
6. Torre-Amione G., Stetson S.J., Youker K.A., et al. Decreased expression of tumor necrosis factor-α in failing human myocardium after mechanical circulatory support. Circulation 100 (1999) 1189-1193
7. Sinagra G., Di Lenarda A., Moretti M., et al. The challenge of cardiomyopathies in 2007. J Cardiovasc Med (Hagerstown) 9 (2008) 545-554
8. Birks E.J., Hall J.L., Barton P.J., et al. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation 112 (2005) I-57-I-64
9. Madigan J.D., Barbone A., Choundhri A.F., et al. Time course of reverse remodelling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 121 (2001) 902-908
10. Seidman J.G., and Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 (2001) 557-567
11. Solaro R.J., and de Tombe P.P. Review focus series: sarcomeric proteins as key elements in integrated control of cardiac function. Cardiovasc Res 77 (2008) 616-618
12. Hall J.L., Birks E.J., Grindle S., et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 28 (2007) 613-627
13. Latif N., Yacoub M.H., George R., et al. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support. J Heart Lung Transplant 26 (2007) 230-235
14. Chen Y., Park S., Li Y., et al. Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 14 (2003) 251-260
15. Kostin S., Rieger M., Dammer S., et al. Gap junction remodeling and altered connexin 43 expression in the failing human heart. Mol Cell Biochem 242 (2003) 135-144
16. Ehler E., Horowits R., Zuppinger C., et al. Alterations at the intercalated disk associated with the absence of muscle LIM protein. J Cell Biol 153 (2001) 763-772
17. Rauch F., Prud'homme J., Arabian A., et al. Heart, brain, and body wall defects in mice lacking calreticulin. Exp Cell Res 256 (2000) 105-111
18. Mesaeli N., Nakamura K., Zvaritch E., et al. Calreticulin is essential for cardiac development. J Cell Biol 144 (1999) 857-868
19. Dai Q., Zhang C., Wu Y., et al. CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J 22 (2003) 5446-5458
20. Pyo R.T., Sui J., Dhume A., et al. CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol 41 (2006) 834-844